Skip to main content
. 2018 May 31;13(6):916–926. doi: 10.2215/CJN.13441217

Table 2.

Donation and health characteristics of the participants (n=123)

Characteristics Australia (n=67) Canada (n=56) All, n (%)
Time since donation, yra
 <1 3 (4) 9 (16) 12 (10)
 1–3 26 (39) 28 (50) 54 (44)
 4–6 16 (24) 16 (29) 32 (26)
 7–10 7 (10) 2 (4) 9 (7)
 >10 6 (9) 0 (0) 6 (5)
Relationship to recipientb
 Spouse 28 (42) 11 (20) 39 (32)
 Parent 17 (25) 16 (29) 33 (27)
 Sibling 15 (22) 8 (14) 23 (19)
 Friend/colleague 2 (3) 7 (13) 9 (7)
 Child 2 (3) 4 (7) 6 (5)
 Other relative 3 (4) 4 (7) 7 (6)
 Nondirected (anonymous) 0 (0) 6 (11) 6 (5)
Kidney paired donation
 Yes 9 (13) 10 (18) 19 (15)
 No 58 (87) 46 (82) 104 (85)
Recipient outcomec
 Alive and functioning graft 61 (91) 52 (93) 113 (92)
 Graft failure or death 6 (9) 4 (7) 10 (8)
Self-reported postdonation complications
 Any 19 (28) 12 (21) 31 (25)
 Mental health 5 (7) 3 (5) 8 (7)
 Hypertension 5 (7) 2 (4) 7 (6)
 Chronic pain 1 (1) 2 (4) 3 (2)
 Hydrocele 2 (3) 0 (0) 2 (2)
 Otherd 8 (12) 5 (9) 13 (11)
a

Total N≠123 due to nonresponse.

b

Unrelated donors comprise 17% of donors in Australia and 40% in Canada (42,43).

c

The timing of the recipient outcome was not captured.

d

Includes hyperthyroidism, low BP, kidney stones, gall stones, hernia, blood clots, endometriosis, gout, high cholesterol, scleritis, and osteoporosis. Note that acute pain and fatigue were not reported as complications, despite being indicated in qualitative data.